premium quality preclinical oncology cro, pioneering the pdx technology for more than 16 years.
xentech is biotech/contract research organization (cro) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (pdx, cdx,...) in addition, xentech develops internal r&d programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets.